Latest News

Addition of PSMA PET led to notable stage migration in mHSPC, study shows
Addition of PSMA PET led to notable stage migration in mHSPC, study shows

January 16th 2025

In total, 40.3% of patients experienced a change in staging between initial assessment on conventional imaging and PSMA PET.

Anktiva targets expanded indication in US and global approvals in EU and UK
Anktiva targets expanded indication in US and global approvals in EU and UK

January 16th 2025

New Drug Application initiated with FDA for TAR-200 for NMIBC
New Drug Application initiated with FDA for TAR-200 for NMIBC

January 15th 2025

EU approves Mona Lisa 2.0 robotic system for prostate cancer
EU approves Mona Lisa 2.0 robotic system for prostate cancer

January 15th 2025

Bladder tumor-focused adaptive radiotherapy shows feasibility in phase 2 trial
Bladder tumor-focused adaptive radiotherapy shows feasibility in phase 2 trial

January 14th 2025

Latest Videos

Latest News

© 2025 MJH Life Sciences

All rights reserved.